5 research outputs found

    Attenuation performance of polymer composites incorporating NZF filler for electromagnetic interference shielding at microwave frequencies

    Get PDF
    Polymer composites have been thoroughly explored for future electromagnetic interference (EMI) applications owing to their unique combination of electrical, mechanical, and optical properties. The composition, morphology, and surface characteristics of the filler material play critical roles in regulating the composite activity. We studied the formation, synthesis and EM attenuation properties of nickel zinc ferrite (NZF) + Polycaprolactone (PCL) microcomposites that were prepared via the conventional mixed oxide (CMO) technique. Compared with other preparation routes, CMO may provide the advantages of a simple process and the ability for mass production and controlled product formation. A rectangular waveguide connected to a vector network analyser coaxial cable was employed to measure the scattering parameters [S] for use in determining the attenuation values of NZF+PCL substrates for a variety of NZF% values. Measurement tests showed a simultaneous increment in the attenuation value with the filler percentage. NZF+PCL samples of 1-mm thickness were able to attenuate microwave frequencies by up to ~3.33 dB, where the highest attenuation magnitude of 8.599 dB over a large area was attributed to the 12.5% NZF filler content at 12 GHz. Thus, a low transmission of waves resulted from the high shielding effectiveness (SE) values that showed a maximum 6.86 dB EM interference. Scanning electron microscopy (SEM) was utilized to analyse the average particle size (1.45 μm) of the filler powder

    SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

    Get PDF
    Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population

    SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

    No full text
    Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.The aim of this study was to inform vaccination prioritization by modelling the impact of vaccination on elective inpatient surgery. The study found that patients aged at least 70 years needing elective surgery should be prioritized alongside other high-risk groups during early vaccination programmes. Once vaccines are rolled out to younger populations, prioritizing surgical patients is advantageous
    corecore